QA: Rhythm Pharmaceuticals INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001649904_2023_Rhythm_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001649904', 'EntityCommonStockSharesOutstanding': 59096454, 'Assets': 332745000, 'AssetsCurrent': 308268000, 'ComprehensiveNetIncome': -184452000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 7028000, 'Liabilities': 162986000, 'LiabilitiesAndStockholdersEquity': 332745000, 'LiabilitiesCurrent': 55203000, 'LiabilitiesNoncurrent': 490000, 'NetIncome': -184678000, 'PropertyPlantAndEquipmentNet': 1341000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 16108000, 'remainder_ComprehensiveNetIncome': 226000, 'remainder_Expenses': 0, 'remainder_Liabilities': 107293000, 'remainder_LiabilitiesAndStockholdersEquity': 169759000, 'remainder_NetIncome': 0, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 10, '00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (calc 2)': 2}}

Graph

Absolute values for 0001649904, Rhythm Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 354,236,000
1 IntangibleAssetsNetIncludingGoodwill 7,883,000
2 PropertyPlantAndEquipmentNet 2,197,000
3 remainder_Assets 18,165,000
4 LiabilitiesCurrent 39,809,000
5 LiabilitiesNoncurrent 1,260,000
6 remainder_Liabilities 77,150,000
7 CostOfGoodsAndServicesSold 2,133,000
8 SellingGeneralAndAdministrativeExpense 92,032,000
9 ResearchAndDevelopmentExpense 108,630,000
10 remainder_Expenses 0
11 remainder_Revenues 23,638,000
12 remainder_NetIncome -1,962,000
13 remainder_ComprehensiveNetIncome -91,000
  yvar yval
0 Assets 382,481,000
1 Liabilities 118,219,000
2 Expenses 202,795,000
3 Revenues 23,638,000
4 StockholdersEquity 264,262,000
5 NetIncome -181,119,000
6 ComprehensiveNetIncome -181,164,500
7 BaseVar 364,593,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.58
9 EconomicCapitalRatio 2.73

Edgar->Model Mapping

Feature Distribution

Change over Time